-

Colossal Announces the Tasmania Thylacine Advisory Committee

As the company makes progress to return the Thylacine to Tasmania, The TTA will play an integral role in community coordination and collaboration

DALLAS & HOBART, Australia--(BUSINESS WIRE)--Colossal Biosciences, the breakthrough genetic engineering and de-extinction company, is pleased to announce the formation of the Tasmania Thylacine Advisory Committee. Led by Tasmanian Mayor Michele Dracoulis, this committee will provide a crucial public body for the discussion, development and dissemination of plans related to the rewilding of the thylacine. Commonly known as the Tasmanian tiger, the slim, striped keystone species was native to Australia, including Tasmania and New Guinea. Last year, Colossal announced plans to de-extinct and return the Thylacine to its native habitat in collaboration with local government, aboriginal representatives, industry leaders, private landowners, university representation and the public at large.

“We are excited to work with this incredible local committee on the next steps of the Thylacine project,” shared Colossal CEO Ben Lamm. “Mayor Dracoulis, business and educational leader James Groom, aboriginal activist Peter Rowe and all the members are helping to ensure we have a complete picture of how reintroduction can support the efforts of the Tasmanian community. From biodiversity improvements to economic opportunities, we want this to help invigorate a community I’ve come to know and love.”

Select Tasmania Thylacine Advisory Committee members include:

  • Mayor Michelle Dracoulis of the Derwent Valley Council
  • Mayor Loueen Triffitt, Tasmanian Aboriginal (Pakana) Ambassador & Cultural Educator and the Mayor of the Central Highlands Council
  • James Groom, principal of Groom Kennedy Lawyers and Advisors and Deputy Chancellor of the University of Tasmania
  • Mia Lindgrin, Associate Dean of Research Performance for Community Consultation and Impact, University of Tasmania
  • Sam Bradley, CEO of the Derwent Experience
  • Todd Babiak, CEO of Brand Tasmania
  • Alex Heroyas, Chief Executive Officer of Destination Southern Tasmania
  • Peter Rowe, Tasmanian Aboriginal Advocate and proud Trawlwoolway man
  • Greg Irons, Director of Bonorong Sanctuary
  • Michael Smith, President of the Derwent Valley and Central Highlands Tourism Association
  • Kennedy Kurwaisimba, Coordinator Forest Products – Planning at Sustainable Timber Tasmania
  • Murray Antill, University of Tasmania School of Creative Arts & Media

“I’m invested in ensuring the best future for Tasmania, which is why I wanted to helm the Tasmania Thylacine Advisory Committee,” said Mayor Michelle Dracoulis, chairwoman of the Colossal Tasmania Thylacine Advisory Committee. “Culturally, on our island, the thylacine is more than an extinct animal. It is part of our identity, and lives strongly in our folklore and imagination. Bringing back the thylacine is an important step in ensuring biodiversity and safeguarding Tasmania for future generations. Its restoration will contribute to much-needed healing in our land which has a troubled past but is home to a people that have hopes for a brighter future.

“I look forward to talking to our Aboriginal groups to inform the members of this exciting project. The thylacine has been a cultural icon of Aboriginal groups throughout Australia for thousands of years and is featured in our ancient rock-art plus it is my own family totem,” shared Peter Rowe, Aboriginal Advocate, Derwent Valley Council Indigenous Advisor and Lawyer. “The Thylacine was an apex predator wiped out by man; from its loss the environment has suffered. Our people work to maintain nature’s balance as part of our duty to care for the Earth.”

“I have spent my career actively working to help Tasmania prosper - socially, commercially and culturally. Joining the Tasmania Thylacine Advisory Committee is an opportunity for me to continue to support our home state and help shape this globally significant and vitally important work,” said James Groom, Senior Tasmanian lawyer and Director.

The TTA will meet quarterly to discuss updates to the project and plans to share information regularly with the broader community. For more information on the TTA, please visit Colossal’s website where information will be routinely updated with advances in scientific research, project progress and a question and comment input form for community discussion.

ABOUT COLOSSAL

Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies. To follow along, please visit: www.colossal.com

WEBSITE & SOCIALS

Websites: www.colossal.com
Twitter: https://twitter.com/itiscolossal
Instagram: ​​https://www.instagram.com/itiscolossal/
LinkedIn: https://www.linkedin.com/company/itiscolossal/
Facebook: https://www.facebook.com/itiscolossal
Hashtag: #itiscolossal

Contacts

R&CPMK:
Emily Mailaender
Emily.Mailaender@rcpmk.com

Colossal Biosciences


Release Versions

Contacts

R&CPMK:
Emily Mailaender
Emily.Mailaender@rcpmk.com

More News From Colossal Biosciences

Colossal Foundation Commits $500,000 to Restore the Bolson Tortoise to the American Southwest

DALLAS--(BUSINESS WIRE)--The Colossal Foundation, the 501(c)(3) charitable organization associated with Colossal, the de-extinction company, today announced a $500,000, 5 year commitment to the Turner Endangered Species Fund (TESF) to advance the recovery and rewilding of the Bolson tortoise (Gopherus flavomarginatus), North America’s largest and rarest tortoise species, within its prehistoric range. Once widespread across the southwestern United States and northern Mexico, the Bolson tortoise...

Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen provides genetic preservation and cloning services for pets, equine, and some of the world’s most endangered species. The Texas-based company will continue to operate under its current leadership as a wholly owned subsidiary of Colossal while expanding its endangered species cloning platform to additio...

Colossal Celebrates the First Birthday of Romulus & Remus

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s only de-extinction company, today celebrates the first birthday of dire wolves Romulus and Remus, the first living dire wolves in thousands of years. Thought to be lost to time, the dire wolves were born one year ago, marking them as the world’s first successfully de-extinct animals in history. Colossal announced the dire wolves to the world in April when Romulus and Remus had just hit 6 months old and their sister Khalessi was 3 months...
Back to Newsroom